Maharashtra Seamless Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 8:30 pm

Quick Insight

Maharashtra Seamless Ltd's current market capitalization stands at ₹9,116 crore, with a P/E ratio of 10.4 and an ROE of 12.9%. The company's strong ROCE of 16.6% indicates efficient capital utilization. With a healthy OPM of 14% and a solid net profit of ₹777 crore, Maharashtra Seamless demonstrates operational strength in the seamless tubes industry. The company's debt-free status, evident from zero borrowings, coupled with a high ICR of 160.99x, underscores its robust financial position. Moreover, the significant promoter holding of 68.04% instills confidence among investors. Maharashtra Seamless appears well-positioned for sustained growth, supported by its sound fundamentals and strategic financial management.

Competitors of Maharashtra Seamless Ltd

All Competitor Stocks of Maharashtra Seamless Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:35 pm

Below is a detailed analysis of the quarterly data for Maharashtra Seamless Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,145.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,418.00 Cr. (Mar 2025) to 1,145.00 Cr., marking a decrease of 273.00 Cr..
• For Expenses, as of Jun 2025, the value is 980.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,133.00 Cr. (Mar 2025) to 980.00 Cr., marking a decrease of 153.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 165.00 Cr.. The value appears to be declining and may need further review. It has decreased from 285.00 Cr. (Mar 2025) to 165.00 Cr., marking a decrease of 120.00 Cr..
• For OPM %, as of Jun 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Mar 2025) to 14.00%, marking a decrease of 6.00%.
• For Other Income, as of Jun 2025, the value is 160.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 160.00 Cr., marking an increase of 120.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 300.00 Cr.. The value appears strong and on an upward trend. It has increased from 299.00 Cr. (Mar 2025) to 300.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 23.00%, marking an increase of 4.00%.
• For Net Profit, as of Jun 2025, the value is 230.00 Cr.. The value appears to be declining and may need further review. It has decreased from 242.00 Cr. (Mar 2025) to 230.00 Cr., marking a decrease of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 17.19. The value appears to be declining and may need further review. It has decreased from 18.06 (Mar 2025) to 17.19, marking a decrease of 0.87.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:52 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 2:18 pm

Below is a detailed analysis of the balance sheet data for Maharashtra Seamless Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 67.00 Cr..
• For Reserves, as of Mar 2025, the value is 6,273.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,664.00 Cr. (Mar 2024) to 6,273.00 Cr., marking an increase of 609.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 693.00 Cr.. The value appears to be improving (decreasing). It has decreased from 852.00 Cr. (Mar 2024) to 693.00 Cr., marking a decrease of 159.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 7,033.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,583.00 Cr. (Mar 2024) to 7,033.00 Cr., marking an increase of 450.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,864.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,950.00 Cr. (Mar 2024) to 1,864.00 Cr., marking a decrease of 86.00 Cr..
• For CWIP, as of Mar 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to 14.00 Cr., marking an increase of 11.00 Cr..
• For Investments, as of Mar 2025, the value is 2,892.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,098.00 Cr. (Mar 2024) to 2,892.00 Cr., marking an increase of 794.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,263.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,533.00 Cr. (Mar 2024) to 2,263.00 Cr., marking a decrease of 270.00 Cr..
• For Total Assets, as of Mar 2025, the value is 7,033.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,583.00 Cr. (Mar 2024) to 7,033.00 Cr., marking an increase of 450.00 Cr..

Notably, the Reserves (6,273.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Maharashtra Seamless Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 70.99. This value is within the healthy range. It has increased from 57.07 (Mar 23) to 70.99, marking an increase of 13.92.
• For Diluted EPS (Rs.), as of Mar 24, the value is 70.99. This value is within the healthy range. It has increased from 57.07 (Mar 23) to 70.99, marking an increase of 13.92.
• For Cash EPS (Rs.), as of Mar 24, the value is 80.89. This value is within the healthy range. It has increased from 69.76 (Mar 23) to 80.89, marking an increase of 11.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 427.36. It has increased from 355.96 (Mar 23) to 427.36, marking an increase of 71.40.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 427.66. It has increased from 356.27 (Mar 23) to 427.66, marking an increase of 71.39.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 403.29. It has decreased from 426.60 (Mar 23) to 403.29, marking a decrease of 23.31.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 101.76. This value is within the healthy range. It has increased from 84.26 (Mar 23) to 101.76, marking an increase of 17.50.
• For PBIT / Share (Rs.), as of Mar 24, the value is 93.57. This value is within the healthy range. It has increased from 73.99 (Mar 23) to 93.57, marking an increase of 19.58.
• For PBT / Share (Rs.), as of Mar 24, the value is 92.94. This value is within the healthy range. It has increased from 71.13 (Mar 23) to 92.94, marking an increase of 21.81.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 72.70. This value is within the healthy range. It has increased from 59.48 (Mar 23) to 72.70, marking an increase of 13.22.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 70.99. This value is within the healthy range. It has increased from 57.07 (Mar 23) to 70.99, marking an increase of 13.92.
• For PBDIT Margin (%), as of Mar 24, the value is 25.23. This value is within the healthy range. It has increased from 19.75 (Mar 23) to 25.23, marking an increase of 5.48.
• For PBIT Margin (%), as of Mar 24, the value is 23.20. This value exceeds the healthy maximum of 20. It has increased from 17.34 (Mar 23) to 23.20, marking an increase of 5.86.
• For PBT Margin (%), as of Mar 24, the value is 23.04. This value is within the healthy range. It has increased from 16.67 (Mar 23) to 23.04, marking an increase of 6.37.
• For Net Profit Margin (%), as of Mar 24, the value is 18.02. This value exceeds the healthy maximum of 10. It has increased from 13.94 (Mar 23) to 18.02, marking an increase of 4.08.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 17.60. This value is within the healthy range. It has increased from 13.37 (Mar 23) to 17.60, marking an increase of 4.23.
• For Return on Networth / Equity (%), as of Mar 24, the value is 16.57. This value is within the healthy range. It has increased from 15.98 (Mar 23) to 16.57, marking an increase of 0.59.
• For Return on Capital Employeed (%), as of Mar 24, the value is 20.36. This value is within the healthy range. It has increased from 18.65 (Mar 23) to 20.36, marking an increase of 1.71.
• For Return On Assets (%), as of Mar 24, the value is 14.44. This value is within the healthy range. It has increased from 13.05 (Mar 23) to 14.44, marking an increase of 1.39.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 23) to 0.00, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 23) to 0.00, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.86. It has decreased from 1.02 (Mar 23) to 0.86, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 24, the value is 8.40. This value exceeds the healthy maximum of 3. It has increased from 5.90 (Mar 23) to 8.40, marking an increase of 2.50.
• For Quick Ratio (X), as of Mar 24, the value is 4.74. This value exceeds the healthy maximum of 2. It has increased from 3.13 (Mar 23) to 4.74, marking an increase of 1.61.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.11. This value is below the healthy minimum of 4. It has decreased from 2.54 (Mar 23) to 2.11, marking a decrease of 0.43.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 7.04. This value is below the healthy minimum of 20. It has increased from 4.38 (Mar 23) to 7.04, marking an increase of 2.66.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.31. This value is below the healthy minimum of 20. It has increased from 3.71 (Mar 23) to 6.31, marking an increase of 2.60.
• For Earning Retention Ratio (%), as of Mar 24, the value is 92.96. This value exceeds the healthy maximum of 70. It has decreased from 95.62 (Mar 23) to 92.96, marking a decrease of 2.66.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.69. This value exceeds the healthy maximum of 70. It has decreased from 96.29 (Mar 23) to 93.69, marking a decrease of 2.60.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 160.99. This value is within the healthy range. It has increased from 29.46 (Mar 23) to 160.99, marking an increase of 131.53.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 116.02. This value is within the healthy range. It has increased from 21.80 (Mar 23) to 116.02, marking an increase of 94.22.
• For Enterprise Value (Cr.), as of Mar 24, the value is 11,266.08. It has increased from 4,966.09 (Mar 23) to 11,266.08, marking an increase of 6,299.99.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.08. This value is within the healthy range. It has increased from 0.86 (Mar 23) to 2.08, marking an increase of 1.22.
• For EV / EBITDA (X), as of Mar 24, the value is 8.26. This value is within the healthy range. It has increased from 4.40 (Mar 23) to 8.26, marking an increase of 3.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.10. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 2.10, marking an increase of 1.27.
• For Retention Ratios (%), as of Mar 24, the value is 92.95. This value exceeds the healthy maximum of 70. It has decreased from 95.61 (Mar 23) to 92.95, marking a decrease of 2.66.
• For Price / BV (X), as of Mar 24, the value is 1.97. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 1.97, marking an increase of 0.97.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.10. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 2.10, marking an increase of 1.27.
• For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.15 (Mar 23) to 0.08, marking a decrease of 0.07.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness